Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, August 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

patent: 2 patents

Citations

dimensions_citation: 120 Dimensions

Readers on

mendeley: 137 Mendeley

Summary News Blogs Patents Dimensions citations

So far, Altmetric has seen 1 news story.

Encouraging SOLAR-1 Trial Results Lead to Alpelisib Approval

Medical Health News, 08 Jul 2019

Since the 1980s, widely applied predictive markers in breast cancer have been limited to HER2 and hormone receptor (HR) status.